Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLISSURE study of estriol vaginal gel for prevention of recurrent urinary tract infection
2018-001481-42Phase 3Active
- Sponsor
- ITF Research Pharma
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in urinary tract infection (UTI) and vaginal atrophy comparing Blissel vaginal gel with Placebo vaginal gel (2 arms). Primary endpoint: Number of urinary tract infection episodes at week 24. Started Sep 2018; status: active.
02
Drugs
estriol
03
Conditions
urinary tract infection (UTI)vaginal atrophy
Beyond the preview
Go deeper on 2018-001481-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001481-42.